1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Iroko

Anonymous board for Iroko

Sort By:
Title
Replies Views
Last Message ↑
  1. Anonymous
    Replies:
    1
    Views:
    1,955
  2. Anonymous
    Replies:
    20
    Views:
    4,513
  3. Anonymous
    Replies:
    15
    Views:
    4,579
  4. Anonymous
    Replies:
    92
    Views:
    15,018
  5. Anonymous
    Replies:
    7
    Views:
    2,299
  6. Anonymous
    Replies:
    23
    Views:
    7,981
  7. Anonymous
    Replies:
    6
    Views:
    3,836
  8. Anonymous
    Replies:
    28
    Views:
    8,015
  9. Anonymous
    Replies:
    8
    Views:
    2,485
  10. Anonymous
    Replies:
    0
    Views:
    1,291
  11. Anonymous
    Replies:
    9
    Views:
    3,507
  12. Anonymous
    Replies:
    55
    Views:
    8,788
  13. Anonymous
    Replies:
    22
    Views:
    6,004
  14. Anonymous
    Replies:
    5
    Views:
    3,900
  15. Anonymous
    Replies:
    2
    Views:
    1,347
  16. Anonymous
    Replies:
    0
    Views:
    1,467
  17. Anonymous
    Replies:
    53
    Views:
    10,663
  18. Anonymous
    Replies:
    2
    Views:
    1,600
  19. Anonymous
    Replies:
    11
    Views:
    4,238
  20. Anonymous
    Replies:
    45
    Views:
    6,831

Thread Display Options

Loading...